Siri Drugs India Profile
Key Indicators
- Authorised Capital ₹ 16.00 Cr
- Paid Up Capital ₹ 7.34 Cr
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2015
- Satisfied Charges ₹ 36.00 Cr
About Siri Drugs India
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232AP2012PTC079367
- Company No.
079367
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2012
- Date of AGM
26 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Siri Drugs India?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mundla Vishnu  | Director | 31-Aug-2015 | Current |
| Prasanth Nandigala | Director | 31-Aug-2015 | Current |
| Teena Tummuri | Additional Director | 17-Oct-2015 | Current |
| Pamidi Ravindra | Director | 31-Aug-2015 | Current |
| Hemanth Nandigala | Additional Director | 17-Oct-2015 | Current |
Financial Performance of Siri Drugs India.
Enhance accessibility to Siri Drugs India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Siri Drugs India?
Unlock access to Siri Drugs India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pokarna LimitedPrasanth Nandigala is a mutual person
Virchow Laboratories LimitedPrasanth Nandigala, Mundla Vishnu and 1 more are mutual person
- Virchow Petrochemical Private Limited
Prasanth Nandigala and Mundla Vishnu are mutual person
- Andhra Organics Limited
Prasanth Nandigala and Mundla Vishnu are mutual person
- Virchow Drugs Limited
Prasanth Nandigala and Pamidi Ravindra are mutual person
Virchow Biotech Private LimitedPrasanth Nandigala, Mundla Vishnu and 1 more are mutual person
Charges (Loans)
₹0
₹36.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of Hyderabad : 21.00 Cr
- Syndicate Bank : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2014 | Syndicate Bank | ₹15.00 Cr | Satisfied |
| 09 Nov 2013 | State Bank Of Hyderabad | ₹21.00 Cr | Satisfied |
How Many Employees Work at Siri Drugs India?
Unlock and access historical data on people associated with Siri Drugs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siri Drugs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siri Drugs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
